Hypofractionated Radiotherapy plus Cetuximab in Locally Advanced Head and Neck Cancer

被引：7
作者：
Teoh, D. C. [1 ]
Rodger, S. [2 ]
Say, J. [2 ]
Hartley, A. [1 ]
机构：
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Fac Med, Birmingham, W Midlands, England
来源：
CLINICAL ONCOLOGY | 2008年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.clon.2008.07.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：717 / 717
页数：1
相关论文
共 4 条
  • [1] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    Bonner, JA
    Harari, PM
    Giralt, J
    Azarnia, N
    Shin, DM
    Cohen, RB
    Jones, CU
    Sur, R
    Raben, D
    Jassem, J
    Ove, R
    Kies, MS
    Baselga, J
    Youssoufian, H
    Amellal, N
    Rowinsky, EK
    Ang, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 567 - 578
  • [2] Cetuximab is effective, but more toxic than reported in the bonner trial
    Lord, H. K.
    Junor, E.
    Ironside, J.
    [J]. CLINICAL ONCOLOGY, 2008, 20 (01) : 96 - 96
  • [3] Carboplatin and hypofractionated accelerated radiotherapy: A dose escalation study of an outpatient chemoradiation schedule for squamous cell carcinoma of the head and neck
    Madhava, K
    Hartley, A
    Wake, M
    Watkinson, JC
    Glaholm, J
    [J]. CLINICAL ONCOLOGY, 2006, 18 (01) : 77 - 81
  • [4] Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
    Pignon, JP
    Bourhis, J
    Domenge, C
    Designé, L
    [J]. LANCET, 2000, 355 (9208) : 949 - 955
1